GA
REGN icon

Geneva Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Geneva Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$2.82M Sell
5,735
-72
-1% -$31.5K 0.05% 164
2017
Q1 		$2.25M Sell
5,807
-863
-13% -$320K 0.04% 193
2016
Q4 		$2.45M Sell
6,670
-62,736
-90% -$23.9M 0.05% 180
2016
Q3 		$27.9M Sell
69,406
-180
-0.3% -$72.2K 0.52% 58
2016
Q2 		$24.3M Sell
69,586
-1,216
-2% -$468K 0.48% 65
2016
Q1 		$25.5M Sell
70,802
-78,950
-53% -$32.5M 0.51% 63
2015
Q4 		$81.3M Sell
149,752
-24,005
-14% -$13M 1.56% 16
2015
Q3 		$80.8M Buy
173,757
+12,343
+8% +$6.63M 1.63% 13
2015
Q2 		$82.3M Buy
161,414
+1,179
+0.7% +$575K 1.47% 18
2015
Q1 		$72.3M Sell
160,235
-39,836
-20% -$16.9M 1.31% 24
2014
Q4 		$82.1M Sell
200,071
-5,573
-3% -$2.19M 1.53% 15
2014
Q3 		$74.1M Buy
205,644
+66,468
+48% +$22.3M 1.4% 18
2014
Q2 		$39.3M Sell
139,176
-54,958
-28% -$16.3M 0.72% 55
2014
Q1 		$58.3M Buy
194,134
+8,793
+5% +$2.71M 1.07% 37
2013
Q4 		$51M Sell
185,341
-250
-0.1% -$71.9K 0.94% 41
2013
Q3 		$58.1M Buy
+185,591
New +$48.8M 1.21% 27

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Geneva Advisors's REGN Position: Q2 2017 in Review

Geneva Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 1.2% in Q2 2017, selling an estimated $31.5K and leaving 5,735 shares worth $2.82M. The position accounts for 0.05% of the portfolio, ranked #164.

Geneva Advisors first reported a position in REGN in Q3 2013 and has held it in 16 quarters since. The position peaked at $82.3M in Q2 2015. 603 funds tracked by Wall St. Rank hold REGN as of Q2 2017.

  • Geneva Advisors held 5,735 shares of Regeneron Pharmaceuticals worth $2.82M as of Q2 2017.
  • Geneva Advisors sold 72 Regeneron Pharmaceuticals shares in Q2 2017, an estimated $31.5K.
  • Regeneron Pharmaceuticals made up 0.05% of Geneva Advisors's portfolio in Q2 2017, its #164 holding.
  • Geneva Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 16 quarters since.
  • Geneva Advisors's Regeneron Pharmaceuticals position peaked at $82.3M in Q2 2015.
  • 603 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.